Article Information
History
- October 13, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Lydia Braunack-Mayer, MSc1,2,
- Josephine Malinga, PhD1,2,†,
- Thiery Masserey, MSc1,2,†,
- Narimane Nekkab, PhD1,2,†,
- Swapnoleena Sen, MSc1,2,
- David Schellenberg, Prof3,
- André-Marie Tchouatieu, MD4,
- Sherrie L Kelly, PhD1,2 and
- Melissa A Penny, PhD1,2,*
- 1Swiss Tropical and Public Health Institute, Allschwil, Switzerland
- 2University of Basel, Basel, Switzerland
- 3London School of Hygiene and Tropical Medicine, London, United Kingdom
- 4Medicines for Malaria Venture, Geneva, Switzerland
- ↵*Correspondence to: Prof Melissa A Penny, Swiss Tropical and Public Health Institute Kreuzstrasse 2, 4123 Allschwil Switzerland, melissa.penny{at}unibas.ch
↵† These authors contributed equally
Posted October 13, 2023.
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study
